Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy

Marti S., Munoz X., Rios J., Morell F., Ferrer J.

Source: Eur Respir J 2006; 27: 689-696
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marti S., Munoz X., Rios J., Morell F., Ferrer J.. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27: 689-696

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006

Sex differences in mortality in patients with COPD
Source: Eur Respir J 2009; 33: 528-535
Year: 2009



Body composition by bioelectrical impedance predicts mortality in COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


The modified BODE index: validation with mortality in COPD
Source: Eur Respir J 2008; 32: 1269-1274
Year: 2008



Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006



Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?
Source: Eur Respir J 2002; 20: 38-42
Year: 2002



Weight loss, food intake and mortality in hospitalized patients with chronic obstructive pulmonary disease (COPD) : The NutritionDay survey analysis
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016

Can body mass index (BMI) predict the likelihood of nocturnal non-invasive home mechanical ventilation (HMV) re-admission rate in chronic hypercapnic chronic obstructive pulmonary disease (CHCOPD)?
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013


CAT predicts mortality in COPD patients who require LTOT
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Does oxygen prescription on discharge lead to a decrease in re-admission rates in chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011

Effect of weight loss on COPD-associated comorbidities in obese COPD
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Drugs (including oxygen) in severe COPD
Source: Eur Respir J 2008; 31: 1114-1124
Year: 2008



Body mass index predicts survival in patients with pulmonary hypertension in chronic lung disease
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019


A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID)
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006


COPD-related morbidity and mortality after smoking cessation: status of the evidence
Source: Eur Respir J 2008; 32: 844-853
Year: 2008



Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Lung function and body weight influence the outcome of pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 356s
Year: 2001

Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007



Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Source: Eur Respir J 2001; 17: 337-342
Year: 2001